PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29601948-7	2018	Specifically, upregulated RNA polymerase I subunit B (POLR1B), DNA polymerase epsilon 3, accessory subunit (POLE3), and DNA polymerase delta 3, accessory subunit (POLD3) were enriched in pathway of pyrimidine metabolism associated with obesity and PCOS, and 5-hydroxytryptamine receptor 2C (HTR2C) was enriched calcium signaling pathway.	pyrimidine	198-208	5-hydroxytryptamine receptor 2C	Homo sapiens	258-289	
31491978-1	2019	Here, we describe the synthesis of disubstituted pyrimidine derivatives and their biological evaluation as selective 5-HT2C agonists.	pyrimidine	49-59	5-hydroxytryptamine receptor 2C	Homo sapiens	117-123	
31491978-5	2019	Thus, pyrimidine 10a could be considered a viable lead compound as a 5-HT2C selective agonist.	pyrimidine	6-16	5-hydroxytryptamine receptor 2C	Homo sapiens	69-75	
29601948-9	2018	CONCLUSIONS: In conclusion, POLR1B, POLE3, POLD3, and HTR2C might play important roles in obese PCOS via involvement of pyrimidine metabolism and calcium signaling pathway.	pyrimidine	120-130	5-hydroxytryptamine receptor 2C	Homo sapiens	54-59	
29601948-7	2018	Specifically, upregulated RNA polymerase I subunit B (POLR1B), DNA polymerase epsilon 3, accessory subunit (POLE3), and DNA polymerase delta 3, accessory subunit (POLD3) were enriched in pathway of pyrimidine metabolism associated with obesity and PCOS, and 5-hydroxytryptamine receptor 2C (HTR2C) was enriched calcium signaling pathway.	pyrimidine	198-208	5-hydroxytryptamine receptor 2C	Homo sapiens	291-296